科室及职务
诊疗专长
| 姓名 | 唐其柱 |
| 出生年月 | 1963年6月 |
| 单位 | 武汉大学人民医院心血管内科 |
| 所属学科 | 临床医学-内科学 |
| 职务、职称及头衔 | 二级教授，主任医师，博士生导师，武汉大学弘毅特聘教授，重大慢病防控与研究教育部国际合作联合实验室主任，代谢与相关慢病湖北省重点实验室主任,武汉大学智慧医疗装备研究院院长 |
| qztang@whu.edu.cn | |
| 联系方式 | 13507192218 |
| 研究方向 |
1.心肌重构和心力衰竭的发病基础和防治研究 2.重大慢病防控综合协同研究 |
| 个人简介 | 长期致力于心血管疾病的防治及科研工作，先后主持“十三五”国家重点研发计划、国家自然科学基金重点项目、区域创新发展联合基金项目、面上项目等10余项。在国内外专业期刊发表论文350余篇(其中SCI收入220余篇)；主编专著7部，主持完成省科技进步一等奖2项，获授权发明专利2项、实用新型专利1项、软著1项。培养硕士研究生57人，博士研究生40人。HEALSAN大数据分析报告显示在中国2023年心血管领域科研最为活跃的医生科学家中排名第6。 |
| 学术任职与荣誉 |
教育部科学技术委员会委员 湖北省医学会副会长兼心血管分会常委 国家“国家级人才计划”百千万工程领军人才(2016年) 卫生部“有突出贡献中青年专家”（2012年） 中国医师奖获得者（2018年） 全国五一劳动奖章获得者（2011年） 湖北省五一劳动奖章获得者（2012年） 湖北省首届医学领军人才（2013年） 武汉大学珞珈杰出学者（2009年）国务院政府特殊津贴（2004年） |
| 教育履历 |
1981.9-1986.6湖北医学院医学系本科学习，获医学学士学位 1988.9-1991.6湖北医学院心血管病学硕士研究生，获医学硕士学位 2000.9-2003.6武汉大学心血管病学博士研究生，获医学博士学位 2004.9-2007.6北京大学中国经济研究中心EMBA，获高级工商管理硕士学位 |
| 工作履历 |
1986.7-1988.8湖北医科大学附属第一医院(湖北省人民医院)内科医师 1991.7-1993.10湖北医科大学附属第一医院(湖北省人民医院)心内科医师 1993.10-1995.9湖北医科大学附属第一医院(湖北省人民医院)心内科主治医师 1995.10-1999.3湖北医科大学附属第一医院(湖北省人民医院)心内科副主任医师、副教授 1999.3-2000.8湖北医科大学附属第一医院(湖北省人民医院)心内科主任医师、副教授 2000.8-2001.1武汉大学人民医院(湖北省人民医院)心内科主任医师、副教授 2001.1-至今武汉大学人民医院(湖北省人民医院)心内科主任医师、教授 1997.8-2000.8湖北医科大学附属第一医院(湖北省人民医院)党委常委、副院长 2000.8-2005.4武汉大学人民医院(湖北省人民医院)党委常委、副院长 2005.4-2014.6武汉大学人民医院(湖北省人民医院)党委书记、副院长 2014.6-2016.9武汉大学人民医院(湖北省人民医院)院长、党委书记 2016.9-2019.11武汉大学人民医院(湖北省人民医院)院长 2019.1-2024.04武汉大学党委常委、副校长兼医学部部长 |
| 成果获奖 |
1、2013年，湖北省科技进步一等奖，第一完成人（心肌重构的发病基础与临床防治） 2、2019年，湖北省科技进步一等奖，第一完成人（心力衰竭的结构重构与防治） 3、2001年，国家科学技术进步二等奖，第四完成人（房室结折返性心动过速的发病基础及射频消融） 4、2011年，国家科学技术进步二等奖，第三完成人（心律失常的结构和神经重构的基础研究与临床防治） 5、2005年，国家科学技术进步二等奖，第九完成人（心房颤动的基础与临床研究） 6、2016年，湖北省科技进步一等奖，第二完成人（心血管病模式动物的构建及其应用） |
| 代表性论著 |
1.
Sai-Yang Xie, Shi-Qiang Liu, Tong Zhang, Wen-Ke Shi, Yun Xing, Wen-Xi Fang,
Min Zhang, Meng-Ya Chen, Si-Chi Xu, Meng-Qi Fan, Lan-Lan Li, Heng Zhang, Nan
Zhao, Zhao-Xiang Zeng, Si Chen, Xiao-Feng Zeng, Wei Deng, Qi-Zhu Tang. USP28
Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and
Cardiac Dysfunction in the Diabetic Heart. Circulation. 2024 Feb
27;149(9):684-706. doi: 10.1161/CIRCULATIONAHA.123.065603. PMID: 37994595.中科院医学1区top影响因子：39 2.Ma Y, Kong C, Guo Z, Wang M, Wang P, Liu F, Yang D, Yang Z, Tang QZ. Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5/NR4a1 axis. Nat Commun. 2024 Jun 4;15(1):4757. doi: 10.1038/s41467-024-48970-2. PMID: 38834564; PMCID: PMC11150406. 2024-06-04中科院医学1区top影响因子：16.6 3. Zhang X, Hu C, Ma ZG, Hu M, Yuan XP, Yuan YP, Wang SS, Kong CY, Teng T, Tang QZ. Tisp40 prevents cardiac ischemia/reperfusion injury through the hexosamine biosynthetic pathway in male mice. Nat Commun. 2023 Jun 8;14(1):3383. doi: 10.1038/s41467-023-39159-0. PMID: 37291168; PMCID: PMC10250363. 2023-06-08中科院医学1区top影响因子：16.6 4. Zhen-Guo Ma, Yu-Pei Yuan, Di Fan, Xin Zhang, Teng Teng, Peng Song, Chun-Yan Kong, Can Hu, Wen-Ying Wei, Qi-Zhu Tang. IRX2 regulates angiotensin II-induced cardiac fibrosis by transcriptionally activating EGR1 in male mice. Nat Commun. 2023 Aug 16;14(1):4967. doi: 10.1038/s41467-023-40639-6. PMID: 37587150; PMCID: PMC1043250.中科院医学1区top影响因子：16.6 5. Xie S, Xu SC, Deng W, Tang Q. Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications. Signal Transduct Target Ther. 2023 Mar 14;8(1):114. doi: 10.1038/s41392-023-01378-8. PMID: 36918543; PMCID: PMC10015017. 2023-03-14中科院医学1区top影响因子：40.8 6. Qiu H, Huang S, Liu Y, Liu L, Guo F, Guo Y, Li D, Cen X, Chen Y, Zhang M, Che Y, Xu M, Tang QZ. Idebenone alleviates doxorubicin-induced cardiotoxicity by stabilizing FSP1 to inhibit ferroptosis. Acta pharmaceutica Sinica.B. 2024 Jun;14(6):2581-2597. doi: 10.1016/j.apsb.2024.03.015. PMID: 38828159; PMCID: PMC1114350.中科院医学1区top影响因子：14.7 7. Qingqing Wu, Qi Yao, Tongtong Hu, Jiabin Yu, Kebing Jiang, Ying Wan, Qi-Zhu Tang. Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2.Cell reports.Medicine. 2023 Dec 19;4(12):101334. doi: 10.1016/j.xcrm.2023.101334. PMID: 38118414; PMCID: PMC10772464.中科院医学1区top影响因子：11.7 8. Chunyan Kong, Zhen Guo, Fangyuan Liu, Nan Tang, Mingyu Wang, Dan Yang, Chenfei Li, Zheng Yang, Yulan Ma, Pan Wang, Qi-zhu Tang. Triad3A-Mediated K48-Linked ubiquitination and degradation of TLR9 impairs mitochondrial bioenergetics and exacerbates diabetic cardiomyopathy. Journal of advanced research. 2024 Jul:61:65-81. doi: 10.1016/j.jare.2023.08.015. PMID: 3762556.中科院医学1区top影响因子：11.4 9. Hu M, Zhang X, Hu C, Ma Z, Wang S, Teng T, Zeng X, Tang QZ. Isthmin-1 alleviates cardiac ischemia/reperfusion injury through cGMP-PKG signaling pathway. Cardiovascular research. 2024 Apr 18:cvae077. doi: 10.1093/cvr/cvae077. PMID: 38637328.中科院医学1区top影响因子：10.8 10. Yu-Ting Liu, Yan Che, Hong-Liang Qiu, Hong-Xia Xia, Yi-Zhou Feng, Jiang-Yang Deng, Yuan Yuan, Qi-Zhu Tang. ADP-ribosylation: An emerging direction for disease treatment. Ageing research reviews. 2024 Feb:94:102176. doi: 10.1016/j.arr.2023.102176. PMID: 3814173.中科院医学1区top影响因子：13.1 11. Tongtong Hu, Qingqing Wu, Qi Yao, Jiabin Yu, Kebing Jiang, Ying Wan, Qi-zhu Tang. PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy. Metabolism. 2023 Sep:146:155658. doi: 10.1016/j.metabol.2023.155658. PMID: 37433344.中科院医学1区top影响因子：10.8 12. Xie S, Xing Y, Shi W, Zhang M, Chen M, Fang W, Liu S, Zhang T, Zeng X, Chen S, Wang S, Deng W, Tang Q. Cardiac fibroblast heat shock protein 47 aggravates cardiac fibrosis post myocardial ischemia-reperfusion injury by encouraging ubiquitin specific peptidase 10 dependent Smad4 deubiquitination. Acta Pharm Sin B. 2022 Nov;12(11):4138-4153. doi: 10.1016/j.apsb.2022.07.022. PMID: 36386478; PMCID: PMC9643299. 2022-08-05中科院医学1区top影响因子：14.7 13. Hu T, Wu Q, Yao Q, Jiang K, Yu J, Tang Q. Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases. Ageing Res Rev. 2022 Nov;81:101706. doi: 10.1016/j.arr.2022.101706. Epub 2022 Aug 4. PMID: 35932976. 2022-08-04中科院医学1区top影响因子：13.1 14. Xie S, Chen M, Fang W, Liu S, Wu Q, Liu C, Xing Y, Shi W, Xu M, Zhang M, Chen S, Zeng X, Wang S, Deng W, Tang Q. Diminished arachidonate 5-lipoxygenase perturbs phase separation and transcriptional response of Runx2 to reverse pathological ventricular remodeling. EBioMedicine. 2022 Dec;86:104359. doi: 10.1016/j.ebiom.2022.104359. PMID: 36395739; PMCID: PMC9672960. 2022-11-14中科院医学1区top影响因子：11.1 15. Yang D, Liu HQ, Yang Z, Fan D, Tang QZ. BMI1 in the heart: Novel functions beyond tumorigenesis. EBioMedicine. 2021 Jan;63:103193. doi: 10.1016/j.ebiom.2020.103193. Epub 2021 Jan 6. PMID: 33421944; PMCID: PMC7804972. 2021-01-06中科院医学1区top影响因子：11.1 16. Hu C, Zhang X, Song P, Yuan YP, Kong CY, Wu HM, Xu SC, Ma ZG, Tang QZ. Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway. Redox Biol. 2020 Oct;37:101747. doi: 10.1016/j.redox.2020.101747. Epub 2020 Oct 7. PMID: 33045622; PMCID: PMC7558217 2020-10-07中科院医学1区top影响因子：11.4 17. Zhang X, Hu C, Kong CY, Song P, Wu HM, Xu SC, Yuan YP, Deng W, Ma ZG, Tang QZ. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death Differ. 2020 Feb;27(2):540-555. doi: 10.1038/s41418-019-0372-z. Epub 2019 Jun 17. PMID: 31209361; PMCID: PMC7206111. 2019-06-17中科院医学1区top影响因子：12.4 18. Ma ZG, Kong CY, Wu HM, Song P, Zhang X, Yuan YP, Deng W, Tang QZ. Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice. Theranostics. 2020 Sep 2;10(24):11013-11025. doi: 10.7150/thno.47516. PMID: 33042267; PMCID: PMC7532690. 2019-09-02中科院医学1区top影响因子：12.4 19. Hu C, Zhang X, Wei W, Zhang N, Wu H, Ma Z, Li L, Deng W, Tang Q. Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKα/UCP2 pathway. Acta Pharm Sin B. 2019 Jul;9(4):690-701. doi: 10.1016/j.apsb.2019.03.003. Epub 2019-03-16. PMID: 31384530; PMCID: PMC6664099. 2019-03-16中科院医学1区top影响因子：14.5 |
| Name | Qizhu Tang |
| Date of birth | Jun, 1963 |
| Department | Department of Cardiology, Renmin Hospital of Wuhan University |
| Title | 2nd Class Full Professor, chief physician, doctoral tutor, Hongyi Distinguished Professor of Wuhan University, Director of the Joint Laboratory of International Cooperation of the Ministry of Education for the Prevention and Control of Major Chronic Diseases, Director of the Hubei Provincial key Laboratory of Metabolism and Related Chronic Diseases, Dean of the Institute of Intelligent Medical Equipment of Wuhan University |
| qztang@whu.edu.cn | |
| TEL | 13507192218 |
| Research Direction | 1. Research on the pathogenesis and prevention of myocardial remodeling and heart failure2. Comprehensive and collaborative research on the prevention and control of major chronic diseases |
| Personal Profile | Long-time devotee of the prevention and treatment of cardiovascular diseases and scientific research, presided over more than 10 projects including the "13th Five-Year Plan" National Key Research and Development Program, the National Natural Science Foundation of Key Project, the National Natural Science Foundation of China Regional Innovation and Development Joint Fund Project, and the National Natural Science Foundation of General Project.Published more than 350 papers in professional journals at home and abroad (including more than 220 SCI papers), edited 7 monographs, presided and completed 2 first prizes of Hubei Province Science and Technology Progress Award, and authorized 2 invention patents, 1 utility model patent and 1 soft. Trained 57 master's students and 40 doctoral students. According to the HEALSAN big data analysis report, Professor Tang ranked 6th among the most active doctors and scientists in the cardiovascular field in China in 2023. |
| Selected Publications |
1.
Sai-Yang Xie, Shi-Qiang Liu, Tong Zhang, Wen-Ke Shi, Yun Xing, Wen-Xi Fang,
Min Zhang, Meng-Ya Chen, Si-Chi Xu, Meng-Qi Fan, Lan-Lan Li, Heng Zhang, Nan
Zhao, Zhao-Xiang Zeng, Si Chen, Xiao-Feng Zeng, Wei Deng, Qi-Zhu Tang. USP28
Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and
Cardiac Dysfunction in the Diabetic Heart. Circulation. 2024 Feb
27;149(9):684-706. doi: 10.1161/CIRCULATIONAHA.123.065603. PMID:
37994595. Chinese Academy of Sciences
Medicine Zone 1 TOP, IF: 39 2.Ma Y, Kong C, Guo Z, Wang M, Wang P, Liu F, Yang D, Yang Z, Tang QZ. Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5/NR4a1 axis. Nat Commun. 2024 Jun 4;15(1):4757. doi: 10.1038/s41467-024-48970-2. PMID: 38834564; PMCID: PMC11150406. 2024-06-04 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 16.6 3. Zhang X, Hu C, Ma ZG, Hu M, Yuan XP, Yuan YP, Wang SS, Kong CY, Teng T, Tang QZ. Tisp40 prevents cardiac ischemia/reperfusion injury through the hexosamine biosynthetic pathway in male mice. Nat Commun. 2023 Jun 8;14(1):3383. doi: 10.1038/s41467-023-39159-0. PMID: 37291168; PMCID: PMC10250363. 2023-06-08 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 16.6 4. Zhen-Guo Ma, Yu-Pei Yuan, Di Fan, Xin Zhang, Teng Teng, Peng Song, Chun-Yan Kong, Can Hu, Wen-Ying Wei, Qi-Zhu Tang. IRX2 regulates angiotensin II-induced cardiac fibrosis by transcriptionally activating EGR1 in male mice. Nat Commun. 2023 Aug 16;14(1):4967. doi: 10.1038/s41467-023-40639-6. PMID: 37587150; PMCID: PMC1043250. Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 16.6 5. Xie S, Xu SC, Deng W, Tang Q. Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications. Signal Transduct Target Ther. 2023 Mar 14;8(1):114. doi: 10.1038/s41392-023-01378-8. PMID: 36918543; PMCID: PMC10015017. 2023-03-14 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 40.8 6. Qiu H, Huang S, Liu Y, Liu L, Guo F, Guo Y, Li D, Cen X, Chen Y, Zhang M, Che Y, Xu M, Tang QZ. Idebenone alleviates doxorubicin-induced cardiotoxicity by stabilizing FSP1 to inhibit ferroptosis. Acta pharmaceutica Sinica.B. 2024 Jun;14(6):2581-2597. doi: 10.1016/j.apsb.2024.03.015. PMID: 38828159; PMCID: PMC1114350. Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 14.7 7. Qingqing Wu, Qi Yao, Tongtong Hu, Jiabin Yu, Kebing Jiang, Ying Wan, Qi-Zhu Tang. Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2.Cell reports.Medicine. 2023 Dec 19;4(12):101334. doi: 10.1016/j.xcrm.2023.101334. PMID: 38118414; PMCID: PMC10772464.Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 11.7 8. Chunyan Kong, Zhen Guo, Fangyuan Liu, Nan Tang, Mingyu Wang, Dan Yang, Chenfei Li, Zheng Yang, Yulan Ma, Pan Wang, Qi-zhu Tang. Triad3A-Mediated K48-Linked ubiquitination and degradation of TLR9 impairs mitochondrial bioenergetics and exacerbates diabetic cardiomyopathy. Journal of advanced research. 2024 Jul:61:65-81. doi: 10.1016/j.jare.2023.08.015. PMID: 3762556. Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 11.4 9. Hu M, Zhang X, Hu C, Ma Z, Wang S, Teng T, Zeng X, Tang QZ. Isthmin-1 alleviates cardiac ischemia/reperfusion injury through cGMP-PKG signaling pathway. Cardiovascular research. 2024 Apr 18:cvae077. doi: 10.1093/cvr/cvae077. PMID: 38637328. Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 10.8 10. Yu-Ting Liu, Yan Che, Hong-Liang Qiu, Hong-Xia Xia, Yi-Zhou Feng, Jiang-Yang Deng, Yuan Yuan, Qi-Zhu Tang. ADP-ribosylation: An emerging direction for disease treatment. Ageing research reviews. 2024 Feb:94:102176. doi: 10.1016/j.arr.2023.102176. PMID: 3814173. Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 13.1 11. Tongtong Hu, Qingqing Wu, Qi Yao, Jiabin Yu, Kebing Jiang, Ying Wan, Qi-zhu Tang. PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy. Metabolism. 2023 Sep:146:155658. doi: 10.1016/j.metabol.2023.155658. PMID: 37433344. Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 10.8 12. Xie S, Xing Y, Shi W, Zhang M, Chen M, Fang W, Liu S, Zhang T, Zeng X, Chen S, Wang S, Deng W, Tang Q. Cardiac fibroblast heat shock protein 47 aggravates cardiac fibrosis post myocardial ischemia-reperfusion injury by encouraging ubiquitin specific peptidase 10 dependent Smad4 deubiquitination. Acta Pharm Sin B. 2022 Nov;12(11):4138-4153. doi: 10.1016/j.apsb.2022.07.022. PMID: 36386478; PMCID: PMC9643299. 2022-08-05 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 14.7 13. Hu T, Wu Q, Yao Q, Jiang K, Yu J, Tang Q. Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases. Ageing Res Rev. 2022 Nov;81:101706. doi: 10.1016/j.arr.2022.101706. Epub 2022 Aug 4. PMID: 35932976. 2022-08-04 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 13.1 14. Xie S, Chen M, Fang W, Liu S, Wu Q, Liu C, Xing Y, Shi W, Xu M, Zhang M, Chen S, Zeng X, Wang S, Deng W, Tang Q. Diminished arachidonate 5-lipoxygenase perturbs phase separation and transcriptional response of Runx2 to reverse pathological ventricular remodeling. EBioMedicine. 2022 Dec;86:104359. doi: 10.1016/j.ebiom.2022.104359. PMID: 36395739; PMCID: PMC9672960. 2022-11-14 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 11.1 15. Yang D, Liu HQ, Yang Z, Fan D, Tang QZ. BMI1 in the heart: Novel functions beyond tumorigenesis. EBioMedicine. 2021 Jan;63:103193. doi: 10.1016/j.ebiom.2020.103193. Epub 2021 Jan 6. PMID: 33421944; PMCID: PMC7804972. 2021-01-06 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 11.1 16. Hu C, Zhang X, Song P, Yuan YP, Kong CY, Wu HM, Xu SC, Ma ZG, Tang QZ. Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway. Redox Biol. 2020 Oct;37:101747. doi: 10.1016/j.redox.2020.101747. Epub 2020 Oct 7. PMID: 33045622; PMCID: PMC7558217 2020-10-07 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 11.4 17. Zhang X, Hu C, Kong CY, Song P, Wu HM, Xu SC, Yuan YP, Deng W, Ma ZG, Tang QZ. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death Differ. 2020 Feb;27(2):540-555. doi: 10.1038/s41418-019-0372-z. Epub 2019 Jun 17. PMID: 31209361; PMCID: PMC7206111. 2019-06-17 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 12.4 18. Ma ZG, Kong CY, Wu HM, Song P, Zhang X, Yuan YP, Deng W, Tang QZ. Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice. Theranostics. 2020 Sep 2;10(24):11013-11025. doi: 10.7150/thno.47516. PMID: 33042267; PMCID: PMC7532690. 2019-09-02 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 12.4 19. Hu C, Zhang X, Wei W, Zhang N, Wu H, Ma Z, Li L, Deng W, Tang Q. Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKα/UCP2 pathway. Acta Pharm Sin B. 2019 Jul;9(4):690-701. doi: 10.1016/j.apsb.2019.03.003. Epub 2019-03-16. PMID: 31384530; PMCID: PMC6664099. 2019-03-16 Chinese Academy of Sciences Medicine Zone 1 TOP, IF: 14.5 |
学术任职与荣誉
科研成果
| 出诊医生 | 星期一 | 星期二 | 星期三 | 星期四 | 星期五 | 星期六 | 星期日 | |||||||
| 上午 | 下午 | 上午 | 下午 | 上午 | 下午 | 上午 | 下午 | 上午 | 下午 | 上午 | 下午 | 上午 | 下午 | |
| 唐其柱 | ||||||||||||||
预约方式
武汉大学人民医院
湖北省人民医院